We are happy to announce the expansion of Postea, with an additional four scripts to serve designers and readers around the world! Postea Multiscript now covers five scripts (Arabic, Cyrillic, Greek, Hebrew, and Latin) and is born of the classic midcentury values of simplicity and impact. It bestows distinction and liveliness, and its lyrical rather than stodgy aesthetic is ideal for branding, signage, corporate typefaces, and magazines.
Learn MoreOur brand new, casual Playpen Sans font family is just one additional step in a long plan of research, publishing data and results, font releases, books, events, and more. So how did we get to this point?
In this article, Veronika Burian and José Scaglione discuss the process, working with Laura Meseguer, and the trajectory of discovery that has happened along the way.
Learn MoreWe released the results from our ongoing Primarium project in 2023 after almost two years of in-depth, worldwide research on handwriting education. A project of this scope is only possible with the rare help of more than 80 collaborating specialists across 40 Latin-based countries, and there’s still more to come. So, from the idea to the research, and from the branded website into the project’s future, what’s the inside scoop on Primarium? Follow the link and this article will explain it all.
Learn MoreRebranding is big business, and it’s also serious work when done well. For these reasons, the Buenos Aires-based FontanaDiseño chose Florian Fecher’s Lektorat type family for BICE’s recent rebranding. The new update includes the creation of a visual image with Lektorat as its typographic voice and its most important branding asset. See how Lektorat is put to great use in this blog post.
Learn MoreEmma Marichal won the 2022 Gerard Unger Scholarship for her Ploquine slab serif font family. Since then she has been diligently working to define its styles, features, and expanding the character set based on its delicately assertive tone. Take a look at its progress on our blog or TypeTogether Premier Partners can now try the Ploquine beta.
Learn More